首页> 外文期刊>Cell biochemistry and function >Mesenchymal stem cells derived-exosomes as a new therapeutic strategy for acute soft tissue injury
【24h】

Mesenchymal stem cells derived-exosomes as a new therapeutic strategy for acute soft tissue injury

机译:间充质干细胞衍生出外泌体作为急性软组织损伤的新治疗策略

获取原文
获取原文并翻译 | 示例
           

摘要

The study aimed to investigate the role of exosomes derived from rat bone marrow mesenchymal stem cells (rBMSCs) in acute soft tissue injury and its related mechanisms. Exosomes were isolated from rBMSCs and characterized by Nanosight NS300 particle size analyser (NTA), transmission electron microscopy (TEM), and western blot. Twenty four rats were randomly divided into four groups (n = 6): control group, strike group, rBMSCs group, and rBMSCs-exo group. Haematoxylin-eosin (HE) staining was used to observe the morphology. Real-time quantification PCR (RT-qPCR) and western blot were used to analyse the expression ofIL-1A,IL-12A,COL11A1,COL4A4, andWnt4. NTA, TEM and western blot results showed that exosomes isolated from rBMSCs were cup-shaped morphology with a size of about 100 nm. HE staining showed that there was severe soft tissue inflammation in strike group, and the symptoms were alleviated after rBMSCs and rBMSCs-exo treatment. RT-qPCR and western blot indicated that in the strike group, the expression levels ofIL-1AandIL-12Awere significantly increased, and their expressions were decreased markedly by exosomes treatment. In addition, after treatment, the expression levels ofCOL11A1andWnt4were up-regulated, while the expression ofCOL4A4was down-regulated. Exosomes isolated from rBMSCs could improve acute soft tissue injury, and may be used as a new therapeutic strategy acute soft tissue injury. Significance of the study Acute soft tissue injury is a common clinical exercise injury, which has a significant impact on people's health and work ability. Exosomes have been attracting increasing attention as a media of cell-to-cell communication. This study showed that exosomes isolated from rBMSCs could improve acute soft tissue injury by inhibiting inflammatory response, regulating the levels ofCOL11A1andCOL4A4, and up-regulating the expression ofWnt4. These will provide a new therapy strategy of acute soft tissue injury, and improve our understanding of the occurrence and development in acute soft tissue injury.
机译:本研究旨在探讨大鼠骨髓间充质干细胞(rBMSCs)外体在急性软组织损伤中的作用及其相关机制。从rBMSCs中分离出外小体,并通过Nanosight NS300粒度分析仪(NTA)、透射电子显微镜(TEM)和western blot进行表征。24只大鼠随机分为4组(n=6):对照组、攻击组、rBMSCs组和rBMSCs exo组。苏木精-伊红(HE)染色观察形态学变化。采用实时定量PCR(RT-qPCR)和western blot分析IL-1A、IL-12A、COL11A1、COL4A4和WNT4的表达。NTA、TEM和western blot结果显示,从RBMSC分离的外显体呈杯状,大小约为100nm。HE染色显示罢工组有严重的软组织炎症,经rBMSCs和rBMSCs exo治疗后症状减轻。RT-qPCR和western blot显示,在打击组中,IL-1和IL-12A的表达水平显著增加,外显体处理显著降低其表达。此外,在治疗后,CO11A1和WNT4的表达水平上调,而COLA4的表达下调。从rBMSCs中分离出的外质体可以改善急性软组织损伤,并可能作为一种新的治疗策略用于急性软组织损伤。急性软组织损伤是临床上常见的运动损伤,对人体健康和工作能力有重要影响。外质体作为细胞间通讯的媒介越来越受到人们的关注。本研究表明,从rBMSCs中分离的外显体可以通过抑制炎症反应、调节C111和COL4A4的水平以及上调Wnt4的表达来改善急性软组织损伤。这将为急性软组织损伤提供一种新的治疗策略,提高我们对急性软组织损伤发生发展的认识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号